UWCCC Molecular Tumor Board Registry
Recruiting
Observational Study
Hematologic Neoplasms
Solid Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- University of Wisconsin, Madison · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Clinically suspected or histologically confirmed solid or hematological malignancy
* Undergoing genetic testing of tumor
* Ability to understand written informed consent document
* Willingness to sign written informed consent document
Exclusion Criteria:
* Pediatric patients…
Contacts